Exchange: NYSE Sector: Healthcare Industry: Medical Distribution
-4.18% $18.12
America/New_York / 8 mai 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 1 386.17 mill |
EPS: | -0.510 |
P/E: | -35.53 |
Earnings Date: | Aug 02, 2024 |
SharesOutstanding: | 76.50 mill |
Avg Daily Volume: | 0.701 mill |
RATING 2024-05-08 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Sell | |
Return On Asset: | Sell | |
DE: | Strong Buy | |
P/E: | Strong Sell | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -35.53 | sector: PE 15.43 |
PE RATIO: COMPANY / INDUSTRY |
---|
-1.38x |
Company: PE -35.53 | industry: PE 25.81 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 17.29 - 18.95 ( +/- 4.58%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Bernocchi Perry A | Sell | 3 890 | Common Stock |
2024-05-01 | Bernocchi Perry A | Sell | 20 204 | Common Stock |
2024-04-22 | Leon Jonathan A | Sell | 5 000 | Common Stock |
2024-03-15 | Bernocchi Perry A | Sell | 14 946 | Common Stock |
2024-03-15 | Leon Jonathan A | Sell | 3 086 | Common Stock |
INSIDER POWER |
---|
-4.59 |
Last 100 transactions |
Buy: 1 227 772 | Sell: 1 362 991 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $18.12 (-4.18% ) |
Volume | 1.061 mill |
Avg. Vol. | 0.701 mill |
% of Avg. Vol | 151.47 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.